# Manistee Therapeutics, Inc. — Form D

Manistee Therapeutics, Inc. of CONCORD, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-07-26. The offering totals $9.5M, of which $9.5M was reported sold. Industry: Other.

## Offering

- Filed: 2021-07-26
- Form: D
- Accession: 0001567619-21-013956
- Industry: Other
- Exemptions: 06b
- Total offering: $9.5M
- Amount sold: $9.5M
- Investors: 6
- Date of first sale: 2021-07-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-407718

## Issuer

- Name: Manistee Therapeutics, Inc.
- CIK: 0001874367
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 84 BARNES HILL ROAD, CONCORD, MA, 01742
- Phone: 617-538-7105

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Robert L Bratzler, Ph.D. | Director | Concord, MA |
| Stephen L Bruso | Director | Concord, MA |
| Bradford J Shingleton, M.D | Director | Concord, MA |
| Robert L Bratzler, Ph.D. | Executive Officer | Concord, MA |
| Bradford J Shingleton, M.D | Executive Officer | Concord, MA |

## More

- [CIK 1874367 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1874367&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001567619-21-013956.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.